These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36964039)

  • 21. [A decade of checkpoint inhibitors: current standard of care and future trends].
    Reischer A; Kruger S; von Bergwelt-Baildon M
    Dtsch Med Wochenschr; 2021 Sep; 146(17):1108-1118. PubMed ID: 34448187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
    Luchini C; Grant RC; Scarpa A; Gallinger S
    Gut; 2021 Oct; 70(10):1809-1811. PubMed ID: 33468535
    [No Abstract]   [Full Text] [Related]  

  • 23. Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).
    Yu S; Xiong G; Zhao S; Tang Y; Tang H; Wang K; Liu H; Lan K; Bi X; Duan S
    Int J Mol Med; 2021 Feb; 47(2):444-454. PubMed ID: 33416134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Checkpoint Blockade and Targeted Therapies in Esophageal Cancer.
    Yang J; Janjigian YY
    Thorac Surg Clin; 2022 Nov; 32(4):467-478. PubMed ID: 36266034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.
    Johanns TM; Miller CA; Dorward IG; Tsien C; Chang E; Perry A; Uppaluri R; Ferguson C; Schmidt RE; Dahiya S; Ansstas G; Mardis ER; Dunn GP
    Cancer Discov; 2016 Nov; 6(11):1230-1236. PubMed ID: 27683556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Checkpoint Blockade in Breast Cancer Therapy.
    Bu X; Yao Y; Li X
    Adv Exp Med Biol; 2017; 1026():383-402. PubMed ID: 29282694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response.
    Navani V; Graves MC; Bowden NA; Van Der Westhuizen A
    Br J Clin Pharmacol; 2020 Sep; 86(9):1736-1752. PubMed ID: 32384184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer: Biomarkers of Response and Resistance.
    Maroun CA; Mandal R
    Otolaryngol Clin North Am; 2021 Aug; 54(4):751-759. PubMed ID: 34116842
    [No Abstract]   [Full Text] [Related]  

  • 30. Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy.
    Zhang Q; Yang C; Gao X; Dong J; Zhong C
    Phytother Res; 2024 Feb; 38(2):776-796. PubMed ID: 38050789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade.
    Correale P; Saladino RE; Giannarelli D; Giannicola R; Agostino R; Staropoli N; Strangio A; Del Giudice T; Nardone V; Altomonte M; Pastina P; Tini P; Falzea AC; Imbesi N; Arcati V; Romeo G; Caracciolo D; Luce A; Caraglia M; Giordano A; Pirtoli L; Necas A; Amler E; Barbieri V; Tassone P; Tagliaferri P
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models.
    Park BC; Stone CA; Dewan AK; Johnson DB
    Immunol Allergy Clin North Am; 2022 May; 42(2):285-305. PubMed ID: 35469619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
    Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J
    Front Immunol; 2020; 11():590072. PubMed ID: 33329575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Educational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma.
    Su D; Kluger H; Olino K
    Ann Surg Oncol; 2024 Mar; 31(3):1865-1879. PubMed ID: 37989956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
    T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
    Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune-checkpoint inhibition to slow cyst growth.
    Wang M
    Nat Rev Nephrol; 2023 Sep; 19(9):541. PubMed ID: 37524862
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance to immune checkpoint blockade: Mechanisms, counter-acting approaches, and future directions.
    Haddad AF; Young JS; Gill S; Aghi MK
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):532-541. PubMed ID: 35276342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Checkpoint Inhibitors in Cancer Therapy.
    Shiravand Y; Khodadadi F; Kashani SMA; Hosseini-Fard SR; Hosseini S; Sadeghirad H; Ladwa R; O'Byrne K; Kulasinghe A
    Curr Oncol; 2022 Apr; 29(5):3044-3060. PubMed ID: 35621637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.
    Ghidini M; Fusco N; Salati M; Khakoo S; Tomasello G; Petrelli F; Trapani D; Petrillo A
    Curr Drug Targets; 2021; 22(9):1021-1033. PubMed ID: 33563194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.
    Markowski MC; Shenderov E; Eisenberger MA; Kachhap S; Pardoll DM; Denmeade SR; Antonarakis ES
    Prostate; 2020 Apr; 80(5):407-411. PubMed ID: 31972048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.